IL15RA (Q13261) variants and mutations
IL15RA (also known as Q13261) is a human protein-coding gene encoding an interleukin-15 receptor subunit alpha protein. It binds IL-15 with high affinity and presents it to neighboring lymphocytes, supporting natural-killer-cell and memory CD8 T-cell development and survival. Disrupted signaling can impair cytotoxic lymphocyte homeostasis, while pathway activation is being exploited therapeutically in cancer immunology. This analysis covers 557 IL15RA variants and mutations. Of these, 82% have computational variant effect predictions. Disease context includes neuroblastoma, non-small cell lung carcinoma, and Sepsis. Example IL15RA variants include A2T, A2V, and P3L.
Variant analysis overview
- Gene: IL15RA
- Protein: Q13261
- UniProt accession: Q13261
- Organism: Homo sapiens
- Variants analyzed: 557
- Variant scope: all variants
- Completed: 2026-08-20
Variant and mutation evidence
- Variant composition: 360 unspecified-consequence records; 10 stop lost; 2 stop retained variant; 120 missense variants; 34 synonymous variants; 10 stop-gained variants; 13 frameshift variants; 1 in-frame insertions; 5 in-frame deletions; 1 splice-region variants; 1 substitution
- Prediction scores: 458 variants have prediction scores (82% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: neuroblastoma, non-small cell lung carcinoma, Sepsis, alcohol drinking, acute respiratory distress syndrome, arthropathy, neoplasm, cancer, acute myeloid leukemia, prostate cancer, immunodeficiency 128, glioblastoma.
Protein structure and variant hotspots
- Protein features: 1 transmembrane segments; 1 domains; 1 post-translational modification sites.
- Structural context: 121 variants have structural context.
- PTM context: 3 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable IL15RA variants
Examples include A2T, A2V, P3L, P3S, R4Q, R5P, R5Q, A6P. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- A2T (p.Ala2Thr), gnomAD rs1838650513, REVEL 0.06, CADD 22.10
- A2V (p.Ala2Val), TOPMed rs1352664130, gnomAD rs1352664130, REVEL 0.04, CADD 22.20
- P3L (p.Pro3Leu), rs2539566263, ClinGen CA375935096, ClinVar RCV004100971, REVEL 0.04, CADD 17.40, Uncertain significance, not specified
- P3S (p.Pro3Ser), TOPMed rs1410804676, gnomAD rs1410804676, REVEL 0.01, CADD 15.50
- R4Q (p.Arg4Gln), TOPMed rs995914515, gnomAD rs995914515, REVEL 0.02, CADD 10.40, Uncertain significance, not specified
- R5P (p.Arg5Pro), TOPMed rs1838648055, gnomAD rs1838648055, REVEL 0.18, CADD 15.80
- R5Q (p.Arg5Gln), TOPMed rs1838648055, gnomAD rs1838648055, REVEL 0.04, CADD 11.60
- A6P (p.Ala6Pro), TOPMed rs1280896130, gnomAD rs1280896130, REVEL 0.16, CADD 16.70
- A6T (p.Ala6Thr), TOPMed rs1280896130, gnomAD rs1280896130, REVEL 0.05, CADD 16.30
- R7C (p.Arg7Cys), rs1233719795, ClinGen CA375935057, ClinVar RCV004208779, TOPMed rs1233719795, REVEL 0.24, CADD 22.10, Uncertain significance, not specified
- R7H (p.Arg7His), TOPMed rs1279339239, gnomAD rs1279339239, REVEL 0.06, CADD 17.00
- R7L (p.Arg7Leu), TOPMed rs1279339239, gnomAD rs1279339239, REVEL 0.10, CADD 12.50
- G8D (p.Gly8Asp), gnomAD rs1311819227, REVEL 0.10, CADD 22.20
- G8S (p.Gly8Ser), TOPMed rs1204286968, gnomAD rs1204286968, REVEL 0.09, CADD 22.30
- R10Q (p.Arg10Gln), Ensembl rs1838645019, REVEL 0.07, CADD 18.60
- R10W (p.Arg10Trp), cosmic curated COSV66092, REVEL 0.07, CADD 18.80
- G13S (p.Gly13Ser), Ensembl rs1249497981, REVEL 0.08, CADD 23.30
- L14I (p.Leu14Ile), gnomAD rs1372795592, REVEL 0.04, CADD 19.30
- L14P (p.Leu14Pro), Ensembl rs2132784950, REVEL 0.19, CADD 23.30
- P15L (p.Pro15Leu), Ensembl rs1838642753, REVEL 0.04, CADD 10.50
- A16T (p.Ala16Thr), TOPMed rs1838642411, REVEL 0.07, CADD 22.20
- L19Q (p.Leu19Gln), gnomAD rs1448833401, REVEL 0.20, CADD 24.10
- L20P (p.Leu20Pro), rs894474179, ClinGen CA202289893, ClinVar RCV004350300, TOPMed rs894474179, REVEL 0.17, CADD 25.00, Uncertain significance, not specified
- L22Q (p.Leu22Gln), Ensembl rs1838639341, REVEL 0.20, CADD 24.30, Uncertain significance, not specified
- L23P (p.Leu23Pro), Ensembl rs1838638452, REVEL 0.29, CADD 23.80
- R24L (p.Arg24Leu), TOPMed rs1055680044, gnomAD rs1055680044, REVEL 0.06, CADD 10.10
- R24P (p.Arg24Pro), TOPMed rs1055680044, gnomAD rs1055680044, REVEL 0.24, CADD 15.60
- R24Q (p.Arg24Gln), TOPMed rs1055680044, gnomAD rs1055680044, REVEL 0.03, CADD 10.40
- R24W (p.Arg24Trp), Ensembl rs1564526877, REVEL 0.14, CADD 24.00
- P25L (p.Pro25Leu), TOPMed rs1173977887, gnomAD rs1173977887, REVEL 0.05, CADD 22.00, Uncertain significance, not specified
- P25S (p.Pro25Ser), gnomAD rs1173529095, REVEL 0.02, CADD 21.00
- P26L (p.Pro26Leu), TOPMed rs1838635942, REVEL 0.06, CADD 22.60
- T28A (p.Thr28Ala), TOPMed rs894167397, gnomAD rs894167397, REVEL 0.05, CADD 20.80
- R29Q (p.Arg29Gln), TOPMed rs1838634033, gnomAD rs1838634033, REVEL 0.04, CADD 9.50
- G30R (p.Gly30Arg), TOPMed rs1838633276, gnomAD rs1838633276, REVEL 0.20, CADD 27.40
- I31M (p.Ile31Met), cosmic curated COSV10749
- I31N (p.Ile31Asn), gnomAD rs1436403569, REVEL 0.10, CADD 22.80
- T32M (p.Thr32Met), 1000Genomes rs145592448, ESP rs145592448, ExAC rs145592448, TOPMed rs145592448, REVEL 0.25, AlphaMissense 0.23
- T32P (p.Thr32Pro), NCI-TCGA Cosmic COSV6609, cosmic curated COSV66092, Variant assessed as somatic; moderate impact.
- T32S (p.Thr32Ser), ESP rs141286489, ExAC rs141286489, TOPMed rs141286489, gnomAD rs141286489, REVEL 0.14, CADD 23.30
- P34H (p.Pro34His), cosmic curated COSV10822
- P34R (p.Pro34Arg), Ensembl rs1836529751, REVEL 0.29, CADD 23.80
- P34S (p.Pro34Ser), ExAC rs779212687, TOPMed rs779212687, gnomAD rs779212687, REVEL 0.14, CADD 18.70
- P35L (p.Pro35Leu), rs1352422115, NCI-TCGA Cosmic COSV1011, cosmic curated COSV10118, gnomAD rs1352422115, REVEL 0.16, AlphaMissense 0.65, Variant assessed as somatic; moderate impact.
- P35S (p.Pro35Ser), NCI-TCGA Cosmic COSV1011, cosmic curated COSV10118, REVEL 0.03, AlphaMissense 0.94, Variant assessed as somatic; moderate impact.
- P36A (p.Pro36Ala), ExAC rs755216367, gnomAD rs755216367, REVEL 0.35, CADD 23.30
- P36H (p.Pro36His), TOPMed rs1177080822, gnomAD rs1177080822
- P36R (p.Pro36Arg), TOPMed rs1177080822, gnomAD rs1177080822, REVEL 0.41, AlphaMissense 0.17
- P36S (p.Pro36Ser), NCI-TCGA TCGA novel, REVEL 0.36, CADD 23.70, Variant assessed as somatic; moderate impact.
- M37C (p.Met37Cys), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- M37T (p.Met37Thr), TOPMed rs1159149440, gnomAD rs1159149440, Likely benign, not specified
- S38F (p.Ser38Phe), Ensembl rs867297993
- S38T (p.Ser38Thr), TOPMed rs1836525886
- V39A (p.Val39Ala), ExAC rs756209755, gnomAD rs756209755, REVEL 0.19, CADD 23.10
- V39M (p.Val39Met), ExAC rs780326185, TOPMed rs780326185, gnomAD rs780326185, REVEL 0.08, CADD 20.70
- E40K (p.Glu40Lys), cosmic curated COSV10532
- H41R (p.His41Arg), cosmic curated COSV66093
- H41Y (p.His41Tyr), cosmic curated COSV10532
- A42S (p.Ala42Ser), 1000Genomes rs374107271, ESP rs374107271, ExAC rs374107271, TOPMed rs374107271, REVEL 0.34, CADD 23.80
- A42T (p.Ala42Thr), cosmic curated COSV66093, 1000Genomes rs374107271, ESP rs374107271, ExAC rs374107271, REVEL 0.34, CADD 24.40
- I44T (p.Ile44Thr), ExAC rs751919191, TOPMed rs751919191, gnomAD rs751919191, REVEL 0.43, CADD 24.50
- I44V (p.Ile44Val), ExAC rs757665187, gnomAD rs757665187, REVEL 0.25, AlphaMissense 0.99
- W45* (p.Trp45Ter), TOPMed rs914011701, gnomAD rs914011701, CADD 32.00
- W45S (p.Trp45Ser), TOPMed rs914011701, gnomAD rs914011701, REVEL 0.11, CADD 0.96
- V46I (p.Val46Ile), 1000Genomes rs144173272, ESP rs144173272, ExAC rs144173272, TOPMed rs144173272, REVEL 0.19, CADD 23.00
- K47R (p.Lys47Arg), cosmic curated COSV66093, 1000Genomes rs149532559, ESP rs149532559, ExAC rs149532559, REVEL 0.26, CADD 23.00
- S48N (p.Ser48Asn), TOPMed rs1836519487, gnomAD rs1836519487, REVEL 0.01, CADD 17.90
- Y49* (p.Tyr49Ter), ExAC rs765886730, TOPMed rs765886730, gnomAD rs765886730, CADD 35.00
- S53F (p.Ser53Phe), TOPMed rs958084508, gnomAD rs958084508, REVEL 0.36, CADD 25.90, Uncertain significance, not specified
- R54M (p.Arg54Met), cosmic curated COSV10118
- E55D (p.Glu55Asp), TOPMed rs1273760405, gnomAD rs1273760405, REVEL 0.26, CADD 22.90
- E55K (p.Glu55Lys), cosmic curated COSV10532, REVEL 0.30, CADD 25.00
- E55Q (p.Glu55Gln), ExAC rs760109906, gnomAD rs760109906, REVEL 0.26, CADD 24.20
- R56P (p.Arg56Pro), ESP rs138176173, ExAC rs138176173, TOPMed rs138176173, gnomAD rs138176173, REVEL 0.57, CADD 25.40
- R56Q (p.Arg56Gln), ESP rs138176173, ExAC rs138176173, TOPMed rs138176173, gnomAD rs138176173, REVEL 0.47, CADD 25.30
- R56W (p.Arg56Trp), rs773161996, ExAC rs773161996, TOPMed rs773161996, gnomAD rs773161996, REVEL 0.61, CADD 24.80, Variant assessed as somatic; moderate impact.
- Y57H (p.Tyr57His), cosmic curated COSV10118, gnomAD rs1284599945, REVEL 0.43, CADD 25.10
- I58S (p.Ile58Ser), NCI-TCGA Cosmic COSV1011, cosmic curated COSV10118, REVEL 0.17, CADD 18.70, Variant assessed as somatic; moderate impact.
- C59F (p.Cys59Phe), ExAC rs774050503, TOPMed rs774050503, gnomAD rs774050503, REVEL 0.87, CADD 24.60
- C59Y (p.Cys59Tyr), cosmic curated COSV66092, ExAC rs774050503, TOPMed rs774050503, gnomAD rs774050503, REVEL 0.87, CADD 24.50, Uncertain significance, not specified
- S61C (p.Ser61Cys), cosmic curated COSV10749
- G62D (p.Gly62Asp), gnomAD rs1836512018, REVEL 0.42, CADD 24.20
- F63S (p.Phe63Ser), ExAC rs768489269, gnomAD rs768489269, REVEL 0.47, CADD 26.00
- K64* (p.Lys64Ter), Ensembl rs1836510673
- R65C (p.Arg65Cys), ExAC rs749538015, gnomAD rs749538015, REVEL 0.50, CADD 24.10
- R65H (p.Arg65His), ExAC rs780359113, gnomAD rs780359113, REVEL 0.40, CADD 25.20
- K66E (p.Lys66Glu), ExAC rs770027176, gnomAD rs770027176, REVEL 0.28, CADD 25.10
- K66N (p.Lys66Asn), Ensembl rs1836507488, REVEL 0.17, CADD 23.50
- K66T (p.Lys66Thr), ExAC rs745895660, gnomAD rs745895660, REVEL 0.33, CADD 25.20
- A67V (p.Ala67Val), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G68S (p.Gly68Ser), ExAC rs757744776, TOPMed rs757744776, gnomAD rs757744776, REVEL 0.32, CADD 23.90, Uncertain significance, not specified
- T69M (p.Thr69Met), rs752103406, NCI-TCGA Cosmic COSV6609, cosmic curated COSV66092, ExAC rs752103406, REVEL 0.23, CADD 24.80, Variant assessed as somatic; moderate impact.
- S70F (p.Ser70Phe), cosmic curated COSV66092
- S71G (p.Ser71Gly), TOPMed rs764671610, REVEL 0.14, CADD 24.00
- S71N (p.Ser71Asn), NCI-TCGA Cosmic COSV6609, cosmic curated COSV66092, Variant assessed as somatic; moderate impact.
- T73A (p.Thr73Ala), NCI-TCGA Cosmic COSV6609, cosmic curated COSV66092, Variant assessed as somatic; moderate impact.
- T73M (p.Thr73Met), 1000Genomes rs555121316, ExAC rs555121316, TOPMed rs555121316, gnomAD rs555121316, REVEL 0.17, CADD 23.20
- E74D (p.Glu74Asp), ESP rs375065387, ExAC rs375065387, TOPMed rs375065387, gnomAD rs375065387, REVEL 0.08, CADD 12.00, Uncertain significance, not specified
- E74K (p.Glu74Lys), NCI-TCGA Cosmic COSV1011, cosmic curated COSV10118, Variant assessed as somatic; moderate impact.
- C75R (p.Cys75Arg), ExAC rs774290864, gnomAD rs774290864, REVEL 0.70, CADD 23.60
- V76A (p.Val76Ala), cosmic curated COSV66092
- V76L (p.Val76Leu), 1000Genomes rs377470890, ExAC rs377470890, TOPMed rs377470890, gnomAD rs377470890, REVEL 0.08, CADD 16.20
- V76M (p.Val76Met), cosmic curated COSV66092, 1000Genomes rs377470890, ExAC rs377470890, TOPMed rs377470890, REVEL 0.11, CADD 20.70
- K79R (p.Lys79Arg), NCI-TCGA Cosmic COSV1011, cosmic curated COSV10118, Variant assessed as somatic; moderate impact.
- A80S (p.Ala80Ser), rs1333884900, ClinGen CA375931571, ClinVar RCV004404955, cosmic curated COSV66093, REVEL 0.00, CADD 10.60, Uncertain significance, not specified
- A80T (p.Ala80Thr), TOPMed rs1333884900, gnomAD rs1333884900, REVEL 0.01, CADD 7.49
- T81M (p.Thr81Met), rs371140892, ClinGen CA5397165, cosmic curated COSV66092, ClinVar RCV004404956, REVEL 0.05, CADD 15.00, Uncertain significance, not specified
- N82I (p.Asn82Ile), cosmic curated COSV66092, REVEL 0.14, CADD 22.90
- V83A (p.Val83Ala), TOPMed rs1459858633, gnomAD rs1459858633
- A84T (p.Ala84Thr), cosmic curated COSV66093, ESP rs141068457, ExAC rs141068457, TOPMed rs141068457, REVEL 0.10, CADD 3.23, Uncertain significance, not specified
- T87A (p.Thr87Ala), ExAC rs778275424, gnomAD rs778275424, REVEL 0.36, CADD 24.10
- T87K (p.Thr87Lys), Ensembl rs1564507501, REVEL 0.31, CADD 24.00
- T88A (p.Thr88Ala), ExAC rs758791677, TOPMed rs758791677, gnomAD rs758791677, REVEL 0.02, CADD 19.20
- T88N (p.Thr88Asn), ExAC rs753007830, TOPMed rs753007830, gnomAD rs753007830, REVEL 0.01, CADD 16.40
- T88S (p.Thr88Ser), ExAC rs753007830, TOPMed rs753007830, gnomAD rs753007830, REVEL 0.02, CADD 16.10
- S90G (p.Ser90Gly), gnomAD rs1411019646, REVEL 0.04, CADD 23.90
- S90N (p.Ser90Asn), gnomAD rs1419375877, REVEL 0.03, CADD 2.83
- L91R (p.Leu91Arg), ExAC rs779223587, TOPMed rs779223587, gnomAD rs779223587, REVEL 0.41, CADD 23.00
- K92E (p.Lys92Glu), TOPMed rs1425518428, gnomAD rs1425518428, REVEL 0.07, CADD 24.00
- K92N (p.Lys92Asn), rs1442938074, gnomAD 10-5949228-T-G, CADD 7.38, SIFT 0.01
- K92T (p.Lys92Thr), rs1646928266, gnomAD 10-5949229-T-G, CADD 6.53, SIFT 0.02
- K92* (p.Lys92Ter), rs1181512692, gnomAD 10-5949230-T-A, CADD 5.98, SIFT 0.05
- R95T (p.Arg95Thr), cosmic curated COSV66092, CADD 11.80
- D96E (p.Asp96Glu), TOPMed rs1486576698, gnomAD rs1486576698, REVEL 0.16, CADD 22.90
- D96H (p.Asp96His), TOPMed rs890250341, gnomAD rs890250341, Uncertain significance, not specified
- D96D (p.Asp96Asp), gnomAD 10-5949132-G-A, CADD 3.80
- D96Y (p.Asp96Tyr), gnomAD 10-5949134-C-A, CADD 0.14, SIFT 0.00
- D96N (p.Asp96Asn), rs764230357, gnomAD 10-5949161-C-T, CADD 9.66, SIFT 0.00
- D96T (p.Asp96Thr), rs554637804, gnomAD 10-5949161-CT-C, CADD 5.09
- D96G (p.Asp96Gly), rs1462905816, gnomAD 10-5949175-T-C, CADD 1.14, SIFT 0.10
- P97A (p.Pro97Ala), 1000Genomes rs148133619, ESP rs148133619, ExAC rs148133619, TOPMed rs148133619, REVEL 0.18, CADD 23.30
- P97L (p.Pro97Leu), gnomAD rs1210202619, REVEL 0.25, CADD 24.30
- A98T (p.Ala98Thr), NCI-TCGA TCGA novel, TOPMed rs1836011711, Variant assessed as somatic; moderate impact.
- A98V (p.Ala98Val), rs8177777, []
- L99V (p.Leu99Val), gnomAD rs1310688175, REVEL 0.16, CADD 23.00
- V100A (p.Val100Ala), cosmic curated COSV66092, REVEL 0.03, CADD 11.30
- V100I (p.Val100Ile), gnomAD rs1309392378
- V100L (p.Val100Leu), gnomAD rs1309392378, REVEL 0.03, CADD 9.99
- H101L (p.His101Leu), Ensembl rs2132468943
- Q102H (p.Gln102His), Ensembl rs1836009741
- Q102R (p.Gln102Arg), rs1833700688, gnomAD 10-5949234-CT-C, CADD 8.22
- Q102* (p.Gln102Ter), rs746122561, gnomAD 10-5949236-G-A, CADD 8.76
- R103K (p.Arg103Lys), rs1833694236, gnomAD 10-5949100-C-T, CADD 4.40
- R103G (p.Arg103Gly), gnomAD 10-5949101-T-C, CADD 5.44
- R103R (p.Arg103Arg), rs1314939853, gnomAD 10-5949108-G-A, CADD 0.25
- R103H (p.Arg103His), rs576371636, gnomAD 10-5949109-C-T, CADD 0.21
- R103L (p.Arg103Leu), rs576371636, gnomAD 10-5949109-C-A, CADD 0.15
- R103S (p.Arg103Ser), rs777987288, gnomAD 10-5949110-G-T, CADD 0.64
- R103C (p.Arg103Cys), rs777987288, gnomAD 10-5949110-G-A, CADD 0.81
- R103I (p.Arg103Ile), gnomAD 10-5949232-C-A, CADD 4.71, SIFT 0.03
- P104L (p.Pro104Leu), gnomAD rs1224725792, REVEL 0.13, CADD 25.30
- P104S (p.Pro104Ser), rs1318247441, ClinGen CA375929638, ClinVar RCV004404957, TOPMed rs1318247441, REVEL 0.12, CADD 23.10, Uncertain significance, not specified
- A105V (p.Ala105Val), cosmic curated COSV66093, ESP rs143835821, ExAC rs143835821, gnomAD rs143835821, REVEL 0.04, CADD 6.30, Likely benign, not specified
- P106L (p.Pro106Leu), gnomAD rs1836007280, REVEL 0.05, CADD 17.30
- P107T (p.Pro107Thr), Ensembl rs557175465, REVEL 0.09, CADD 22.60
- S108F (p.Ser108Phe), cosmic curated COSV66093
- S108L (p.Ser108Leu), gnomAD 10-5949238-G-A, CADD 4.34, SIFT 0.05
- S108R (p.Ser108Arg), rs989143740, gnomAD 10-5949240-G-C, CADD 7.08, SIFT 0.45
- S108S (p.Ser108Ser), rs989143740, gnomAD 10-5949240-G-A, CADD 7.45, SIFT 1.00
- V110L (p.Val110Leu), TOPMed rs766534160, gnomAD rs766534160, REVEL 0.02, CADD 16.60
- T111M (p.Thr111Met), rs41294171, ClinGen CA5397137, cosmic curated COSV66093, ClinVar RCV000950183, REVEL 0.03, CADD 21.40, Benign, not provided
- T112M (p.Thr112Met), ESP rs146869620, ExAC rs146869620, TOPMed rs146869620, gnomAD rs146869620, REVEL 0.09, CADD 23.90
- A113T (p.Ala113Thr), rs781347002, gnomAD 10-5949194-C-T, CADD 1.31, SIFT 0.14
- A113P (p.Ala113Pro), rs781347002, gnomAD 10-5949194-C-G, CADD 1.07, SIFT 0.04
- A113S (p.Ala113Ser), rs781347002, gnomAD 10-5949194-C-A, CADD 0.99, SIFT 0.03
- G114A (p.Gly114Ala), ExAC rs765137239, TOPMed rs765137239, gnomAD rs765137239
- G114V (p.Gly114Val), ExAC rs765137239, TOPMed rs765137239, gnomAD rs765137239, REVEL 0.06, CADD 22.60
- V115A (p.Val115Ala), ExAC rs776748920, gnomAD rs776748920, REVEL 0.07, CADD 24.90
- V115G (p.Val115Gly), ExAC rs776748920, gnomAD rs776748920, REVEL 0.16, CADD 26.30
- V115L (p.Val115Leu), 1000Genomes rs541349922, ExAC rs541349922, TOPMed rs541349922, gnomAD rs541349922, REVEL 0.02, CADD 15.30
- V115M (p.Val115Met), 1000Genomes rs541349922, ExAC rs541349922, TOPMed rs541349922, gnomAD rs541349922, REVEL 0.05, CADD 18.40
- V115V (p.Val115Val), gnomAD 10-5949204-G-T, CADD 0.41
- V115D (p.Val115Asp), rs1213104061, gnomAD 10-5949205-A-T, CADD 4.41, SIFT 0.03
- V115I (p.Val115Ile), rs778715086, gnomAD 10-5949206-CAGAG-, CADD 3.23
- V115F (p.Val115Phe), rs1564476207, gnomAD 10-5949206-C-A, CADD 3.65, SIFT 0.03
- T116I (p.Thr116Ile), cosmic curated COSV10118, ExAC rs766571757, TOPMed rs766571757, gnomAD rs766571757, REVEL 0.24, CADD 24.40
- T116N (p.Thr116Asn), ExAC rs766571757, TOPMed rs766571757, gnomAD rs766571757, REVEL 0.14, CADD 24.00
- Q118* (p.Gln118Ter), TOPMed rs1836000690, gnomAD rs1836000690, CADD 38.00
- Q118E (p.Gln118Glu), TOPMed rs1836000690, gnomAD rs1836000690
- P119L (p.Pro119Leu), ExAC rs760783060, gnomAD rs760783060, REVEL 0.10, CADD 25.50
Public IL15RA analysis runs
- IL15RA analysis run — IL15RA (557 variants) — completed 2026-08-20